We have located links that may give you full text access.
Transcranial Direct Current Stimulation Modulates the Brain's Response to Foot Stimuli under Dual-task Condition: A fMRI Study in Elderly Adults.
Neuroscience Letters 2018 October 3
Previous behavioral studies have shown that high-intensity cognitive tasks weaken balance control in elder adults. Moreover, age-related loss of plantar sensation is considered to be an important contributing factor to the occurrence of falls. Recently, we have realized that transcranial direct current stimulation (tDCS) can effectively improve the balance of the elderly under the dual-task, but its underlying regulatory mechanism is not clear. In this study, task functional Magnetic Resonance Imaging (fMRI) was used to study the brain's response to foot stimuli under foot stimuli or dual-task (foot stimuli and cognitive task) conditions to explain the effect of the addition of cognitive tasks during balance in 16 healthy elderly adults. To study whether tDCS would counteract the effect of the added cognitive task, we further compared the differences in activity of the cerebral cortices of dual-task and tDCS-dual-task conditions. The results suggested added cognitive tasks significantly attenuated the response of the brain to foot stimuli in elderly adults. Moreover, the cortex excitability weakened by cognitive tasks was significantly promoted after 20 min of tDCS. In conclusion, a portion of the resources originally used for plantar sensory processing may be assigned to the processing of the cognitive task when the cognitive tasks are added, which results in insufficient resources for plantar sensory processing. tDCS improves the ability of the brain to respond to foot stimuli by modulating the excitability of the cognitive cortex and reverses the effects of cognitive tasks.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app